CDKN2A/p19ARF Polyclonal Antibody, Biotin Conjugated
Product Specifications
Background
Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
Synonyms
Arf; Alternative reading frame; smARF; p19ARF; p19; Cyclin-dependent kinase inhibitor 2A, isoforms 1/2; Cyclin-dependent kinase 4 inhibitor A; Tumor suppressor ARF; Cdkn2a
Gene ID
12578
Swiss Prot
Q64364
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Rat
Immunogen
65-169/169
Target
CDKN2A/p19ARF
Clonality
Polyclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from mouse CDKN2A/p19ARF
Applications
ELISA, IHC-P, IHC-F
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
12578
Predicted Cross Reactivity
Mouse
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400270-100 1x 100 µL
Fibronectin (HFN7.1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740977-500 1x 500 µL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 